CENTERCROSS Logo (WIPO, 08.03.2018)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke CENTERCROSS wurde als Wortmarke am 08.03.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1426604 |
| Länder | 
|
| Basismarke |
Nr. 87824811,
07. März 2018
|
| Anmeldedatum | 08. März 2018 |
| Ablaufdatum | 11. Oktober 2021 |
Markeninhaber
400 Seaport Court,
Suite 103
US
Suite 103
US
Markenvertreter
Seventh Floor Offices
Artillery House
GB
Waren und Dienstleistungen
10
Surgical and medical apparatus, instruments and devices for
use in the prevention and treatment of circulatory system
issues and conditions; surgical and medical apparatus,
instruments and devices for use in the prevention and
treatment of pulmonary embolisms, thrombus, deep vein
thrombosis, peripheral arterial occlusions, blood clots,
vascular issues and conditions, intracranial haemorrhages,
cerebral haemorrhages, hematomas, peripheral vascular
lesions, and coronary vascular lesions; medical and surgical
catheters for use in the prevention and treatment of
circulatory system issues and conditions; medical and
surgical catheters for use in the prevention and treatment
of pulmonary embolisms, thrombus, deep vein thrombosis,
peripheral arterial occlusions, blood clots, vascular issues
and conditions, intracranial haemorrhages, cerebral
haemorrhages, hematomas, peripheral vascular lesions, and
coronary vascular lesions; catheters and microcatheters;
parts and fittings for all the aforesaid goods
41
Education services, namely, developing, arranging and
conducting educational programmes and providing courses of
instruction in the fields of healthcare, the use of
pharmaceuticals and medical devices, medical research,
surgery, medical science, medicine and in the fields of the
prevention and treatment of circulatory system issues and
conditions, namely, pulmonary embolisms, thrombus, deep vein
thrombosis, peripheral arterial occlusion, blood clots,
vascular issues and conditions, intracranial haemorrhages,
cerebral haemorrhages, hematomas, peripheral vascular
lesions, and coronary vascular lesions, and distribution of
course material in connection therewith; training in the use
and operation of medical devices and medical research
apparatus and consultation relating thereto; educational
services, namely, conducting live and online seminars,
classes, workshops, lectures, panel discussions, and
training programs in the fields of health care and medical
diseases, disorders and related treatments and in the fields
of the prevention and treatment of circulatory system issues
and conditions, namely, pulmonary embolisms, thrombus, deep
vein thrombosis, peripheral arterial occlusion, blood clots,
vascular issues and conditions, intracranial haemorrhages,
cerebral haemorrhages, hematomas, peripheral vascular
lesions, and coronary vascular lesions, and distribution of
course material in connection therewith; educational
services, namely, providing non-downloadable webinars in the
fields of health care and medical diseases, disorders and
related treatments in relation to the prevention and
treatment of circulatory system issues and conditions,
namely, pulmonary embolisms, thrombus, deep vein thrombosis,
peripheral arterial occlusion, blood clots, vascular issues
and conditions, intracranial haemorrhages, cerebral
haemorrhages, hematomas, peripheral vascular lesions, and
coronary vascular lesions, and distribution of course
material in connection therewith; provision of educational
content, namely, providing on-line instruction in the fields
of health care and medical diseases, disorders and related
treatments in relation to the prevention and treatment of
circulatory system issues and conditions, namely, pulmonary
embolisms, thrombus, deep vein thrombosis, peripheral
arterial occlusion, blood clots, vascular issues and
conditions, intracranial haemorrhages, cerebral
haemorrhages, hematomas, peripheral vascular lesions, and
coronary vascular lesions, and distribution of course
material in connection therewith; providing information
about medical education in the fields of healthcare,
pharmaceuticals, medical devices, medical research, surgery,
medical science and medicine and patient care via computer,
electronic and on-line databases; advisory services in the
field of medical education; educational services, namely,
conducting live and online seminars, classes, workshops,
lectures, panel discussions and training in the fields of
healthcare, pharmaceuticals, medical devices, medical
research, surgery, medical science and medicine; educational
services, namely, providing non-downloadable webinars in the
fields of healthcare, pharmaceuticals, medical devices,
medical research, surgery, medical science and medicine and
distribution of course material in connection therewith;
providing non-downloadable electronic publications in the
nature of teaching guides, instructional materials,
brochures, and course books in the fields of healthcare, the
use of pharmaceuticals and medical devices, medical
research, surgery, medical science, medicine and in relation
to the prevention and treatment of circulatory system issues
and conditions, namely, pulmonary embolisms, thrombus, deep
vein thrombosis, peripheral arterial occlusion, blood clots,
vascular issues and conditions, intracranial haemorrhages,
cerebral haemorrhages, hematomas, peripheral vascular
lesions, and coronary vascular lesions; providing
information about medical education in the fields of
healthcare, pharmaceuticals, medical devices, medical
research, surgery, medical science and medicine via
electronic online databases
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 07. Juni 2022 | 2022/28 Gaz | US | RAW: Total Ceasing Effect |
| 29. September 2021 | 2021/43 Gaz | MX | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 21. Februar 2020 | 2020/9 Gaz | MX | Ablehnung |
| 27. September 2019 | 2019/40 Gaz | NO | Ablehnung |
| 23. September 2019 | 2019/39 Gaz | CH | Ablehnung |
| 23. Mai 2019 | 2019/21 Gaz | AU | Ablehnung |
| 25. April 2019 | 2019/17 Gaz | RS | Ablehnung |
| 25. März 2019 | 2019/13 Gaz | TR | Ablehnung |
| 22. März 2019 | 2019/12 Gaz | NZ | Ablehnung |
| 06. März 2019 | 2019/10 Gaz | EM | Ablehnung |
| 25. Februar 2019 | 2019/11 Gaz | CN | Ablehnung |
| 09. Januar 2019 | 2019/2 Gaz | GB | Ablehnung |
| 08. März 2018 | 2018/38 Gaz | US | Eintragung |
ID: 141426604